Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Bell

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
Biorxiv : the Preprint Server for Biology|June 4, 2025
Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiationYuchao Ni, Dong Lin, Mingchen Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy SpectrumLucia Nappi, Marisa Thi, Amy Lum, et al.
Frontiers in Cardiovascular Medicine|December 24, 2021
Myocardial Perfusion Imaging After Severe COVID-19 Infection Demonstrates Regional Ischemia Rather Than Global Blood Flow ReductionGeorge D Thornton, Abhishek Shetye, Dan S Knight, et al.
Communicable Diseases Intelligence Quarterly Report|November 6, 2002
OzFoodNet: enhancing foodborne disease surveillance across Australia: quarterly report, January to March 2002Rosie Ashbolt, Robert Bell, Scott Crerar, et al.
Communicable Diseases Intelligence Quarterly Report|June 22, 2005
OzFoodNet: enhancing foodborne disease surveillance across Australia: quarterly report, October to December 2004Rosie Ashbolt, Jenny Barralet, Robert Bell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced CancerAmita Patnaik, Paul Haluska, Anthony W Tolcher, et al.
Oncotarget|May 4, 2018
PD-L1 expression in medulloblastoma: an evaluation by subgroupAllison M Martin, Christopher J Nirschl, Magda J Polanczyk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
Iatrogenic Exserohilum infection of the central nervous system: mycological identification and histopathological findingsW Robert Bell, Justin B Dalton, Chad M McCall, et al.
BMJ Open Respiratory Research|November 12, 2021
Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individualsMelissa Heightman, Jai Prashar, Toby E Hillman, et al.
Cell Reports|August 4, 2015
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Biorxiv : the Preprint Server for Biology|June 4, 2025
Longitudinal single-cell analysis reveals RUNX1T1 as an early driver in treatment-induced neuroendocrine transdifferentiationYuchao Ni, Dong Lin, Mingchen Shi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 26, 2019
Developing a Highly Specific Biomarker for Germ Cell Malignancies: Plasma miR371 Expression Across the Germ Cell Malignancy SpectrumLucia Nappi, Marisa Thi, Amy Lum, et al.
Frontiers in Cardiovascular Medicine|December 24, 2021
Myocardial Perfusion Imaging After Severe COVID-19 Infection Demonstrates Regional Ischemia Rather Than Global Blood Flow ReductionGeorge D Thornton, Abhishek Shetye, Dan S Knight, et al.
Communicable Diseases Intelligence Quarterly Report|November 6, 2002
OzFoodNet: enhancing foodborne disease surveillance across Australia: quarterly report, January to March 2002Rosie Ashbolt, Robert Bell, Scott Crerar, et al.
Communicable Diseases Intelligence Quarterly Report|June 22, 2005
OzFoodNet: enhancing foodborne disease surveillance across Australia: quarterly report, October to December 2004Rosie Ashbolt, Jenny Barralet, Robert Bell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
A First-in-Human Phase I Study of the Oral p38 MAPK Inhibitor, Ralimetinib (LY2228820 Dimesylate), in Patients with Advanced CancerAmita Patnaik, Paul Haluska, Anthony W Tolcher, et al.
Oncotarget|May 4, 2018
PD-L1 expression in medulloblastoma: an evaluation by subgroupAllison M Martin, Christopher J Nirschl, Magda J Polanczyk, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 11, 2012
Iatrogenic Exserohilum infection of the central nervous system: mycological identification and histopathological findingsW Robert Bell, Justin B Dalton, Chad M McCall, et al.
BMJ Open Respiratory Research|November 12, 2021
Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individualsMelissa Heightman, Jai Prashar, Toby E Hillman, et al.
Cell Reports|August 4, 2015
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate CancerShusuke Akamatsu, Alexander W Wyatt, Dong Lin, et al.
Pageof 21